Sandoz: EU Stakeholders Must Stand Up For Proper Competition Behavior
Company’s Legal Head Also Calls For EPO TO Further Leverage Capabilities
Sandoz and Teva were among representatives discussing intellectual property and other legal challenges during the first day of Medicines for Europe’s 2022 annual conference. The European Commission’s Directorate-General for Competition director, Paul Csiszár, added his insight on legal issues.
